Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports

Atopic Dermatitis

Dupilumab Therapy in a Patient with Atopic Dermatitis and Severe Atopic Keratoconjunctivitis

J Eur Acad Dermatol Venereol.

Gkalpakiotis S, Arenberger P, Skalicka P, Arenbergerova M

doi: 10.1111/jdv.16278.

Immunodeficiency

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Pediatr Allergy Immunol.

Soresina A, Moratto D, Chiarini M, Paolillo C, Baresi G, Focà E, Bezzi M, Baronio B, Giacomelli M, Badolato R

doi: 10.1111/pai.13263.

Allergic Diseases

Blocking type 2 inflammation by dupilumab does not control classic (Type 1-driven) allergic contact dermatitis in chronic hand eczema

Contact Dermatitis.

Crepy MN, Nosbaum A, Bensefa-Colas L

doi: 10.1111/cod.13266.

AcneAtopic Dermatitis

A case of Atopic dermatitis and Hidradenitis Suppurativa successfully treated with Dupilumab

J Eur Acad Dermatol Venereol.

Gambardella A, Calabrese G, Di Brizzi EV, Alfano R, Argenziano G

doi: 10.1111/jdv.16280.

Atopic Dermatitis

Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year-Old Girl

Case Rep Pediatr.

Bothou C, Alexopoulos A, Dermitzaki E, Kleanthous K, Papadimitriou A, Mastorakos G, Papadimitriou DT

doi: 10.1155/2018/9643543.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description

J Eur Acad Dermatol Venereol.

Larrondo J, Cabrera R, Gosch M, Larrondo F, Aylwin M, Castro A

doi: 10.1111/jdv.16732.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection

J Eur Acad Dermatol Venereol.

Ehsani AH, Nasimi M, Bigdelo Z

doi: 10.1111/jdv.16579.

Atopic Dermatitis

Infective Endocarditis Associated with Atopic Dermatitis

Int Heart J.

Aoyagi S, Oda T, Wada K, Nakamura E, Kosuga T, Yasunaga H

doi: 10.1536/ihj.17-078.

Mucositis Secondary to Chlamydia pneumoniae Infection: Expanding the Mycoplasma pneumoniae-Induced Rash and Mucositis Concept

Pediatr Dermatol.

Mayor-Ibarguren A, Feito-Rodriguez M, González-Ramos J, Del Rosal-Rabes T, González-Sainz FJ, Sánchez-Orta A, de Lucas-Laguna R

doi: 10.1111/pde.13140.

Related content

Dupilumab Therapy in a Patient with Atopic Dermatitis and Severe Atopic Keratoconjunctivitis

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Blocking type 2 inflammation by dupilumab does not control classic (Type 1-driven) allergic contact dermatitis in chronic hand eczema

A case of Atopic dermatitis and Hidradenitis Suppurativa successfully treated with Dupilumab

Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year-Old Girl

Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection

Infective Endocarditis Associated with Atopic Dermatitis

Mucositis Secondary to Chlamydia pneumoniae Infection: Expanding the Mycoplasma pneumoniae-Induced Rash and Mucositis Concept